| 12/02 | Insider Sell: Johnson & Johnson | MT |
| 12/02 | Pfizer to Spend More Than $2.5 Billion to Expand Plants in Belgium, Ireland | MT |
| 12/02 | Vaxxinity's Phase 3 COVID-19 Vaccine Trial Meets Endpoints | MT |
| 12/02 | Pfizer Plans EUR1.2 Billion Investment in Belgium | MT |
| 12/02 | MT Hoejgaard Wins DKK600 Million Contract to Build New Factory for Novo Nordisk | MT |
| 12/02 | Rigel Pharmaceuticals Shares Leap Premarket on FDA OK of Rezlidhia | DJ |
| 12/02 | Sanofi Says Any Potential Offer for Horizon Therapeutics Will Be Made in Cash | MT |
| 12/01 | Transcript : Pfizer Inc. Presents at 5th Annual Evercore ISI HealthCONx Confe.. | CI |
| 12/01 | Strong Eurozone Manufacturing Data Pushes European Bourses to Close Mostly Higher | MT |
| 12/01 | Global markets live: General Electric, Tesla, Apple, Salesforce, Boe.. | |
| 12/01 | Eli Lilly and Co.'s Unit Completes Negotiations With Canadian Drug Accessibility Allian.. | MT |
| 12/01 | Pfizer Aims to Double Production at Dublin Plant With 1.2 Billion-Euro Investment | MT |
| 12/01 | Transcript : AbbVie Inc. Presents at Piper Sandler 34th Annual Healthcare Con.. | CI |
| 12/01 | Morgan Stanley Adjusts Price Target on Johnson & Johnson to $178 From $170, Maintains E.. | MT |
| 12/01 | Lilly Wraps Up Acquisition of Akouos | MT |
| 12/01 | Roivant Sciences Launches Subsidiary With Pfizer to Develop Drug Candidate for Inflamma.. | MT |
| 12/01 | Roivant Sciences and Pfizer Forms New Vant Company Focused on Developing TL1A Drug Cand.. | CI |
| 12/01 | Abbvie Inc. Announces Provincial Reimbursement for RINVOQ (Upadacitinib) for the Treatm.. | CI |
| 12/01 | Pfizer, Valneva Say Lyme Disease Vaccine Candidate Shows Antibody Levels Remain Above B.. | MT |
| 12/01 | Eli Lilly Says Phase 3 Study of Alzheimer's Disease Drug Candidate Meets All Endpoints | MT |
| 12/01 | Valneva, Pfizer Tout Six-month Antibody Persistence Data for Lyme Disease Vaccine Candi.. | MT |
| 12/01 | Valneva-Pfizer's Lyme Disease Jab Continues To Provide Protection Six Months Post-vacci.. | MT |
| 12/01 | Valneva and Pfizer Report Six-Month Antibody Persistence Data in Children and Adults fo.. | CI |
| 12/01 | Eli Lilly and Company (NYSE:LLY) completed the acquisition o.. | CI |
| 12/01 | Carrick Therapeutics, Ltd. announced that it has received $60 million in funding from a.. | CI |
| 11/30 | US FDA Cancels Emergency Use Approval For Eli Lilly's COVID-19 Treatment | MT |
| 11/30 | Eli Lilly and Company Shares Positive Donanemab Data in First Active Comparator Study i.. | CI |
| 11/30 | Johnson & Johnson Chief Executive Joaquin Duato to Also Assume Chairman Role | MT |
| 11/30 | Johnson & Johnson CEO Joaquin Duato to Become Chairman of the Board | DJ |
| 11/30 | Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board | CI |
| 11/30 | Sector Update: Health Care Carried Higher by Surging Biotechs | MT |
| 11/30 | FDA pulls U.S. authorization for Eli Lilly's COVID drug bebtelovimab | RE |
| 11/30 | Eli Lilly's Bebtelovimab COVID-19 Drug Reportedly Paused by US FDA | MT |
| 11/30 | FDA Pauses Authorization for Eli Lilly's Bebtelovimab COVID Drug | MT |
| 11/30 | Sector Update: Health Care Stocks Still Struggling for Direction Wednesday.. | MT |
| 11/30 | Sector Update: Health Care | MT |
| 11/30 | Transcript : Eli Lilly and Company Presents at 5th Annual Evercore ISI Health.. | CI |
| 11/30 | AC Immune Says Alzheimer's Vaccine Candidate Tapped for Further Development; Shares Ris.. | MT |
| 11/30 | Eli Lilly's Buyout Offer Accepted by 81% Akouos Shareholders at Closing | MT |
| 11/29 | Sanofi in Early Deal Talks with Horizon Therapeutics | MT |
| 11/29 | Merck KGaA Enters Clinical Trial Partnership For Investigational Bladder Cancer Combo T.. | MT |
| 11/29 | Horizon Therapeutics Confirms 'Highly Preliminary Discussions' With Three Suitors -- Sh.. | MT |
| 11/29 | Eli Lilly Earnings, Revenue Set to Grow in 2023 With 'Modest' Impact From New Launches,.. | MT |
| 11/29 | Transcript : AbbVie Inc. Presents at 5th Annual Evercore ISI HealthCONx Confe.. | CI |
| 11/29 | Immutep Signs Trial Collaboration, Supply Deal With Pfizer, Merck KGaA for Urothelial C.. | MT |
| 11/29 | Immutep Strikes Clinical Trial Collaboration with Merck, Pfizer for Urothelial Cancer T.. | MT |
| 11/28 | Immutep Enters second Collaboration with Pfizer and Merck KGaA | CI |
| 11/28 | Strand Therapeutics Inc. announced that it has received $44.529393 million in funding f.. | CI |
| 11/25 | Sun Pharmaceutical's Psoriatic Arthritis Drug Up for Strong Sales Once Available | MT |
| 11/25 | Elon Musk says Twitter's verified service with colors to start next week | RE |
| 11/25 | NOVO NORDISK : Berenberg reaffirms its Neutral rating | MD |
| 11/24 | Researchers test mRNA technology for universal flu vaccine | RE |
| 11/23 | European Commission Orders Treatment Courses Of Pfizer's COVID-19 Pill | MT |
| 11/23 | Sector Update: Health Care Stocks Advancing Wednesday Afternoon | MT |
| 11/23 | Sector Update: Health Care Stocks Still Advancing in Wednesday Trading | MT |
| 11/23 | Sector Update: Health Care | MT |
| 11/23 | Eurozone PMI Data Supports European Equities | MT |
| 11/23 | Correction: Fed Minutes Eyed for Signs of Slower Fed Rate Hikes as ETFs, Stoc.. | MT |
| 11/23 | Fed Minutes Eyed for Signs of Slower Fed Rate Hikes as ETFs, Stock Futures Inch Higher .. | MT |
| 11/23 | PFIZER INC : From Sell to Buy by Credit Suisse | MD |
| 11/23 | Johnson & Johnson's Janssen Pharmaceutical Says Phase 3 Trial of Major Depressive Disor.. | MT |
| 11/23 | AbbVie Says European Commission Approves Skyrizi for Treatment of Crohn's Disease | MT |
| 11/23 | AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatm.. | CI |
| 11/22 | Australia's CSL prices hemophilia gene therapy at $3.5 million | RE |
| 11/22 | CDC Says Pfizer-BioNTech, Moderna New Boosters Better Than Older Formulation in COVID-1.. | MT |
| 11/22 | Factbox-Pharmacies, drug companies settle lawsuits over U.S. opioid crisis | RE |
| 11/22 | Teva, AbbVie finalize $6.6 billion U.S. opioid settlements | RE |
| 11/22 | Teva, Allergan Finalize Terms of Nationwide Opioid Settlement -- Update | DJ |
| 11/22 | Berenberg Bank Raises Eli Lilly and Co. PT to $375 From $345, Says Underlying Performan.. | MT |
| 11/22 | Arvinas, Inc. Announces Initial Results from Phase 2 Cohort Expansion Portion of Phase .. | CI |
| 11/22 | Shionogi's Covid-19 Drug Gets Panel Approval in Japan | DJ |
| 11/22 | Buying in Public Sector Bank Stocks Aids Indian Equities Snap Losing Run; IndusInd Bank.. | MT |
| 11/22 | Glenmark Pharmaceuticals Reaches Settlement with Pfizer Over Kidney Cancer Drug | MT |
| 11/22 | Novo Nordisk Invests $743.6 Million to Expand Clinical Manufacturing Facilities | DJ |
| 11/22 | Novo Nordisk to Spend $744 Million to Expand Clinical Active Pharma Ingredients Capacit.. | MT |
| 11/22 | Novo Nordisk Invests DKK 5.4 billion Danish Kroner in Expansion of Clinical Manufacturi.. | CI |
| 11/21 | Glenmark Pharmaceuticals Reaches Settlement Agreement with Pfizer for Axitinib Tablets,.. | CI |
| 11/21 | Novo Nordisk Agrees to $40 Million Milestone Payment to Prothena | MT |
| 11/21 | Prothena Achieves $40 Million Clinical Milestone Payment From Novo Nordisk | DJ |
| 11/21 | Insider Sell: Johnson & Johnson | MT |
| 11/21 | AbbVie Says Epcoritamab Obtains FDA Priority Review for Treatment of Large B-Cell Lymph.. | MT |
| 11/21 | AbbVie, Genmab Get FDA Priority Review of Epcoritamab in Large B-Cell Lymphoma | DJ |
| 11/21 | AbbVie Inc. Announces Acceptance of Biologics License Application for Epcoritamab by U... | CI |
| 11/21 | Aosaikang Pharma Wins Nod to Market Variant of Pfizer's Breast Cancer Drug | MT |
| 11/18 | Pfizer's Updated Omicron Booster Shows Improved Immunity Against New Variants | MT |
| 11/18 | Transcript : Pfizer Inc. Presents at 4th Annual Wolfe Research Healthcare Con.. | CI |
| 11/18 | Pfizer, BioNTech Says Bivalent COVID-19 Vaccine Shows 'Greater' Response | MT |
| 11/18 | Credit Suisse Starts Eli Lilly at Outperform With $395 Price Target | MT |
| 11/18 | Credit Suisse Starts AbbVie at Outperform With $170 Price Target | MT |
| 11/18 | Credit Suisse Starts Johnson & Johnson at Neutral With $170 Price Target | MT |
| 11/18 | Credit Suisse Starts Pfizer at Outperform With $55 Price Target | MT |
| 11/18 | Pfizer, BioNTech Say Bivalent COVID-19 Booster Showed Improved Immune Response Against .. | MT |
| 11/18 | Pfizer/BioNTech Omicron shot shows immune response against BQ.1.1 in older adults | RE |
| 11/18 | Pfizer and BioNTech Report New Data on Omicron BA.4/BA.5-Adapted Bivalent Booster Demon.. | CI |
| 11/18 | Factbox-Twitter 2.0: Musk warns of bankruptcy, flip-flops on blue ch.. | RE |
| 11/18 | Factbox-Advertisers react to Twitter's new ownership | RE |
| 11/18 | Analyst recommendations: AbbVie, Bristol-Myers, Dominion Energy,.. | |
| 11/18 | Big Pharma may have to reveal government deals in WHO's draft pandemic rules | RE |
| 11/17 | CytomX Therapeutics Shares Rally on Regeneron Pact | DJ |
| 11/17 | Morgan Stanley Slashes Price Target on Eli Lilly to $436 From $441, Affirms Overweight .. | MT |
Google
Twitter
Facebook
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
